Anavex Life Sciences Corp (AVXL)

[falconer66a]

No. Off by 66.6%.

"No worries" implies 100% certainty that in the end good execution will....

In fact, Anavex Life Sciences Corp will thrive should it achieve only a 33.3% "certainty."

If clinical results in all three, 100% of the clinical trials now concluding are positive, the company will have great success. The three trials: a) Rett syndrome (phenomenal murine and early human data), b) Parkinson's disease dementia (strong murine safety and efficacy outcomes), and c) Alzheimer's disease (long, continuing record of safety and desire of clinical subjects to continue taking the drug).

But things Anavex will be very fine if only one of these clinical trials yields positive results that allow regulatory approval for sales and use of blarcamesine. In the light of both early clinical trial results in humans, along with profound safety and efficacies in murine CNS disease models, probabilities of all three trials failing are minute. Quite the opposite is likely.

But, success if only one trial "succeeds."